title: Understanding the mechanism of atovaquone drug resistance in Plasmodium falciparum cytochrome b mutation Y268S using computational methods.
abstract: The rapid appearance of resistant malarial parasites after introduction of atovaquone (ATQ) drug has prompted the search for new drugs as even single point mutations in the active site of Cytochrome b protein can rapidly render ATQ ineffective. The presence of Y268 mutations in the Cytochrome b (Cyt b) protein is previously suggested to be responsible for the ATQ resistance in Plasmodium falciparum (P. falciparum). In this study, we examined the resistance mechanism against ATQ in P. falciparum through computational methods. Here, we reported a reliable protein model of Cyt bc1 complex containing Cyt b and the Iron-Sulphur Protein (ISP) of P. falciparum using composite modeling method by combining threading, ab initio modeling and atomic-level structure refinement approaches. The molecular dynamics simulations suggest that Y268S mutation causes ATQ resistance by reducing hydrophobic interactions between Cyt bc1 protein complex and ATQ. Moreover, the important histidine contact of ATQ with the ISP chain is also lost due to Y268S mutation. We noticed the induced mutation alters the arrangement of active site residues in a fashion that enforces ATQ to find its new stable binding site far away from the wild-type binding pocket. The MM-PBSA calculations also shows that the binding affinity of ATQ with Cyt bc1 complex is enough to hold it at this new site that ultimately leads to the ATQ resistance.
authors.affiliation: Department of Bioinformatics, Systems Toxicology Group, CSIR-Indian Institute of Toxicology Research, Lucknow, India.
authors.forename: Bashir A
authors.initials: BA
authors.lastname: Akhoon
authors.affiliation: Department of Bioinformatics, Systems Toxicology Group, CSIR-Indian Institute of Toxicology Research, Lucknow, India.
authors.forename: Krishna P
authors.initials: KP
authors.lastname: Singh
authors.affiliation: Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh, India.
authors.forename: Megha
authors.initials: M
authors.lastname: Varshney
authors.affiliation: Department of Bioinformatics, Biocenter, Am Hubland, University of Würzburg, Würzburg, Germany.
authors.forename: Shishir K
authors.initials: SK
authors.lastname: Gupta
authors.affiliation: Department of Proteomics, CSIR-Indian Institute of Toxicology Research, Lucknow, India; Academy of Scientific and Innovative Research (AcSIR), New Delhi, India.
authors.forename: Yogeshwar
authors.initials: Y
authors.lastname: Shukla
authors.affiliation: Department of Bioinformatics, Systems Toxicology Group, CSIR-Indian Institute of Toxicology Research, Lucknow, India; Academy of Scientific and Innovative Research (AcSIR), New Delhi, India.
authors.forename: Shailendra K
authors.initials: SK
authors.lastname: Gupta
mesh_terms: D000962:Antimalarials / Q000494:pharmacology* / Q000627:therapeutic use; D053626:Atovaquone / Q000494:pharmacology* / Q000627:therapeutic use; D003198:Computer Simulation; D045303:Cytochromes b / Q000235:genetics*; D004351:Drug Resistance / Q000235:genetics*; D016778:Malaria, Falciparum / Q000188:drug therapy; D009154:Mutation; D010963:Plasmodium falciparum / Q000235:genetics*
chemical_list: D000962:Antimalarials; D045303:Cytochromes b; D053626:Atovaquone